Biocon share news, announcements and annual reports
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Biocon Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2004
Last close ₹350.70up ₹18.25 (5.49%)BSE ₹350.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹332.45.
28 Oct: open ₹331.45, high ₹350.70, low ₹330.60
52-week range of traded prices to 28 Oct 2026
₹318.40Low, 23 Oct 2026₹447.15High, 16 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,153 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 115.39
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 63.89
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.68
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 42,59,63748.1% delivered
Biocon has 1,771 announcements on record, routine notices left out; 7 in the 30 days to 29 Oct 2026, the latest on 29 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Biocon quarterly results
Nov4Wed
The board meets on 4 Nov 2026 to consider financial results
Notice filed 26 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Biocon annual reports, presentations and earnings calls
The company's own documents, latest first.Biocon financials, year by year
Annual reports17
- Annual report, year to Mar 202615 Jul 2026
- Annual report, year to Mar 202517 Jul 2025
- Annual report, year to Mar 202418 Jul 2024
- Annual report, year to Mar 202320 Jul 2023, a zip file
- Annual report, year to Mar 20225 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202129 Jun 2021, a zip file
- Annual report, year to Mar 20201 Jul 2020, a zip file
- Annual report, year to Mar 201928 Jun 2019, a zip file
- Annual report, year to Mar 201828 Jul 2018, a zip file
- Annual report, year to Mar 20171 Aug 2017, a zip file
- Annual report, year to Mar 20162 Aug 2016, a zip file
- Annual report, year to Mar 20153 Jul 2015, a zip file
- Annual report, year to Mar 201426 Jun 2014, a zip file
- Annual report, year to Mar 201217 Oct 2013, a zip file
- Annual report, year to Mar 20134 Jul 2013, a zip file
- Annual report, year to Mar 201115 Jul 2011, a zip file
- Annual report, year to Mar 201018 Aug 2010, a zip file
Investor presentations49
- Investor Presentation6 Aug 2026
- Investor Presentation1 Jun 2026
- Investor Presentation8 May 2026
- Investor Presentation25 Feb 2026
- Investor Presentation13 Feb 2026
44 earlier presentations
- Investor Presentation9 Dec 2025
- Presentation6 Dec 2025
- Investor Presentation12 Nov 2025
- Investor Presentation8 Aug 2025
- Investor Presentation12 May 2025
- Investor Presentation9 May 2025
- Corporate Presentation3 Feb 2025
- Presentation31 Jan 2025
- Presentation30 Oct 2024
- Corporate Presentation23 Sep 2024
- Corporate Presentation19 Aug 2024
- Investor Presentation27 Jun 2024
- Investor Presentation9 Feb 2024
- Investor Presentation17 Nov 2023
- Presentation11 Nov 2023
- Investor Presentation11 Aug 2023
- Investor Presentation24 May 2023
- Investor Presentation17 Feb 2023
- Investor Presentation15 Nov 2022
- Investor Presentation27 Jul 2022
- Updated Investor Presentation-Q4 FY22.29 Apr 2022
- Investor Presentation28 Apr 2022
- Investor Presentation on Biocon Biologics to acquire Viatris Biosimilars Business.1 Mar 2022
- Investor Presentation20 Jan 2022
- Investor Presentation2 Nov 2021
- Investor Presentation21 Sep 2021
- Investor Presentation19 May 2021
- Investor Presentation1 Apr 2021
- Investor Presentation on Biocon Biologics Transforming Healthcare. Transforming Lives.18 Sep 2020
- Investor Presentation11 Jun 2020
- Investor Presentation8 Jun 2020
- Investor Presentation10 Feb 2020
- Investor Presentation13 Dec 2019
- Investor Presentation11 Dec 2019
- Investor Presentation_Revised11 Sep 2019
- Investor Presentation9 Sep 2019
- Investor Presentation13 Jun 2019
- Investor Presentation27 May 2019
- Investor Presentation6 Feb 2019
- Investor Presentation16 Nov 2018
- Investor Presentation2 Sep 2018
- Investor Presentation31 May 2018, a zip file
- Investor Presentation5 Feb 2018, a zip file
- Investor Presentation8 Nov 2017, a zip file
Earnings calls35
- Transcript11 Aug 2026
- Link of Recording6 Aug 2026
- Transcript14 May 2026
- Link of Recording8 May 2026
- Transcript17 Feb 2026
30 earlier call documents
- Link of Recording13 Feb 2026
- Transcript18 Nov 2025
- Link of Recording12 Nov 2025
- Transcript14 Aug 2025
- Link of Recording8 Aug 2025
- Transcript15 May 2025
- Link of Recording9 May 2025
- Transcript7 Feb 2025
- Link of Recording31 Jan 2025
- Transcript7 Nov 2024
- Link of Recording31 Oct 2024
- Transcript19 Aug 2024
- Presentation and Link of Recording10 Aug 2024
- Transcript23 May 2024
- Presentation and Link of Recording17 May 2024
- Transcript16 Feb 2024
- Presentation and Link of Recording9 Feb 2024
- Transcript20 Nov 2023
- Link of Recording11 Nov 2023
- Transcript21 Aug 2023
- Transcript31 May 2023
- Earnings Call Presentation and Link of Recording24 May 2023
- Transcript of Earnings Call Q3 FY2322 Feb 2023
- Presentation and Video Recording of Q3 FY23 Earnings Call15 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call22 Nov 2022
- Presentation and Video Recording of Q2 FY23 Earnings Call15 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call3 Aug 2022
- Presentation and video recording of Q1 FY23 Earnings Call28 Jul 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call6 May 2022
- Presentation and Video Recording of Q4 FY22 Earnings Call29 Apr 2022
Biocon merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Amalgamation/Merger7 Feb 2020
Biocon share news and announcements
Newest first. Page 1 of 36.
Oct 2026
26 Oct · Analysts
26 Oct · Board meeting
26 Oct · Updates
14 Oct · Updates
10 Oct · General Updates
1 Oct · Options to purchase securities
Sep 2026
25 Sep · Updates
9 Sep · General Updates
8 Sep · Analysts
Aug 2026
31 Aug · Analysts
28 Aug · General Updates
25 Aug · Updates
18 Aug · Updates
11 Aug · Analysts
7 Aug · Analysts
5 Aug · Business
5 Aug · Results
3 Aug · General Updates
Jul 2026
29 Jul · Updates
28 Jul · Analysts
28 Jul · Board meeting
22 Jul · Management
16 Jul · Updates
15 Jul · Meeting
Jun 2026
29 Jun · Business
22 Jun · General Updates
10 Jun · Business
8 Jun · Analysts
May 2026
29 May · Meeting
27 May · Analysts
21 May · General Updates
21 May · Analysts
11 May · Updates
9 May · Meeting
8 May · Business
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 7 Aug 2026Board or managers changeddown 2.35%−2.3 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−3.5 pts vs Nifty 500) · volume 0.8× usual · delivery −0.1 pts against usual · The announcement
- 6 Aug 2026Resultsup 2.68%+2.7 pts vs Nifty 500market median −0.7% · five sessions +0.5% (+0.8 pts vs Nifty 500) · volume 1.6× usual · delivery −22.5 pts against usual · The announcement
- 8 May 2026Resultsdown 0.48%−0.1 pts vs Nifty 500market median −0.7% · five sessions +9.6% (+12.2 pts vs Nifty 500) · volume 1.8× usual · delivery −26.1 pts against usual · The announcement
- 13 Feb 2026Resultsup 0.77%+2.2 pts vs Nifty 500market median −0.7% · five sessions +2.0% (+3.5 pts vs Nifty 500) · volume 1.6× usual · delivery −27.8 pts against usual · The announcement
- 1 Feb 2026Buybackup 0.38%+2.4 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−1.2 pts vs Nifty 500) · volume 2.3× usual · delivery −20.0 pts against usual · The announcement
- 17 Dec 2025Credit ratingup 0.31%+0.6 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+2.9 pts vs Nifty 500) · volume 0.3× usual · delivery +2.4 pts against usual · The announcement
- 10 Dec 2025Credit ratingdown 1.17%−0.7 pts vs Nifty 500market median 0.0% · five sessions +0.3% (+0.1 pts vs Nifty 500) · volume 0.5× usual · delivery −4.0 pts against usual · The announcement
- 12 Nov 2025Resultsup 5.40%+4.7 pts vs Nifty 500market median −0.7% · five sessions +9.5% (+8.9 pts vs Nifty 500) · volume 6.5× usual · delivery −11.1 pts against usual · The announcement
- 31 Oct 2025Credit ratingdown 1.19%−0.6 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+2.4 pts vs Nifty 500) · volume 0.9× usual · delivery +8.8 pts against usual · The announcement
- 22 Sep 2025Buybackdown 1.91%−1.5 pts vs Nifty 500market median 0.0% · five sessions −8.2% (−4.9 pts vs Nifty 500) · volume 1.3× usual · delivery +16.0 pts against usual · The announcement
20 earlier announcements
- 8 Aug 2025Resultsdown 5.72%−4.6 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−1.3 pts vs Nifty 500) · volume 1.2× usual · delivery −18.4 pts against usual · The announcement
- 9 May 2025Resultsdown 1.40%−0.6 pts vs Nifty 500market median −0.7% · five sessions +1.2% (−3.1 pts vs Nifty 500) · volume 2.0× usual · delivery −16.9 pts against usual · The announcement
- 9 May 2025Dividenddown 1.40%−0.6 pts vs Nifty 500market median 0.0% · five sessions +1.2% (−3.1 pts vs Nifty 500) · volume 2.0× usual · delivery −16.9 pts against usual · The announcement
- 16 Apr 2025Credit ratingup 0.09%−0.5 pts vs Nifty 500market median 0.0% · five sessions +2.1% (−2.4 pts vs Nifty 500) · volume 0.6× usual · delivery −0.4 pts against usual · The announcement
- 2 Apr 2025Board or managers changedup 0.87%−0.1 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−2.2 pts vs Nifty 500) · volume 0.4× usual · delivery −9.7 pts against usual · The announcement
- 31 Jan 2025Board or managers changedup 1.55%+0.2 pts vs Nifty 500market median 0.0% · five sessions +9.3% (+7.0 pts vs Nifty 500) · volume 1.1× usual · delivery −9.8 pts against usual · The announcement
- 23 Jan 2025Credit ratingup 2.38%+1.7 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−7.6 pts vs Nifty 500) · volume 0.5× usual · delivery +2.0 pts against usual · The announcement
- 27 Nov 2024Credit ratingup 1.70%+1.1 pts vs Nifty 500market median 0.0% · five sessions +6.0% (+4.0 pts vs Nifty 500) · volume 1.2× usual · delivery +3.4 pts against usual · The announcement
- 31 Oct 2024Resultsdown 1.43%−1.2 pts vs Nifty 500market median −0.7% · five sessions +0.7% (−0.6 pts vs Nifty 500) · volume 4.9× usual · delivery −21.3 pts against usual · The announcement
- 2 Sep 2024Credit ratingup 1.20%+1.1 pts vs Nifty 500market median 0.0% · five sessions +4.1% (+5.1 pts vs Nifty 500) · volume 1.3× usual · delivery −7.7 pts against usual · The announcement
- 26 Jul 2024Board or managers changedup 1.84%+0.2 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−4.5 pts vs Nifty 500) · volume 1.9× usual · delivery −5.6 pts against usual · The announcement
- 17 May 2024Dividendup 0.03%−0.6 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+0.5 pts vs Nifty 500) · volume 1.0× usual · delivery −2.3 pts against usual · The announcement
- 15 Mar 2024Board or managers changeddown 5.89%−5.4 pts vs Nifty 500market median 0.0% · five sessions −7.0% (−6.9 pts vs Nifty 500) · volume 1.3× usual · delivery −4.5 pts against usual · The announcement
- 9 Feb 2024Board or managers changeddown 3.97%−3.8 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−3.9 pts vs Nifty 500) · volume 2.6× usual · delivery −5.1 pts against usual · The announcement
- 8 Feb 2024Credit ratingdown 1.91%−1.3 pts vs Nifty 500market median 0.0% · five sessions −6.4% (−5.5 pts vs Nifty 500) · volume 0.9× usual · delivery −11.3 pts against usual · The announcement
- 20 Dec 2023Board or managers changeddown 3.86%−1.8 pts vs Nifty 500market median 0.0% · five sessions +0.2% (−0.5 pts vs Nifty 500) · volume 1.1× usual · delivery −9.5 pts against usual · The announcement
- 1 Dec 2023Credit ratingup 0.99%+0.3 pts vs Nifty 500market median 0.0% · five sessions +1.7% (−2.3 pts vs Nifty 500) · volume 1.0× usual · delivery −0.6 pts against usual · The announcement
- 12 Nov 2023Resultsup 3.25%+2.6 pts vs Nifty 500market median −0.7% · five sessions +2.4% (+0.4 pts vs Nifty 500) · volume 0.6× usual · delivery −7.1 pts against usual · The announcement
- 10 Oct 2023Board or managers changeddown 0.98%−2.0 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−3.9 pts vs Nifty 500) · volume 0.9× usual · delivery +2.4 pts against usual · The announcement
- 20 Sep 2023Board or managers changed0.00%+0.9 pts vs Nifty 500market median 0.0% · five sessions −4.2% (−2.3 pts vs Nifty 500) · volume 1.2× usual · delivery −6.8 pts against usual · The announcement
Biocon results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.